Activity of daptomycin against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae
Metadatos
Mostrar el registro completo del ítemAutor
Sorlozano Puerto, Antonio; Gutiérrez Fernández, José; Roman, Juan; Liébana Ureña, José; Piédrola Angulo, GonzaloEditorial
Mary Ann Liebert, Inc.
Fecha
2009-06Referencia bibliográfica
Sorlozano A, Gutiérrez J, Roman J, Liebana J, Piedrola G. Activity of daptomycin against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae. Microb Drug Resist. 2009 Jun;15(2):125-7. DOI: 10.1089/mdr.2009.0899
Resumen
The activity of daptomycin against 141 Staphylococcus aureus and 63 Streptococcus agalactiae isolates was assessed. The isolates were previously characterized and showed resistance to the antibiotics normally used against gram-positive cocci. Daptomycin was active against 100% of the isolates (minimum inhibitory concentration [MIC(90)] = 0.5 microg/ml, for both species). This antibiotic shows good in vitro activity; therefore, it is an excellent therapeutic alternative against these isolates.